Humana November 2017 Pharmaceutical Policy Updates

Humana Medical Policy Updates
Humana Medical Policy Updates

Click here to view the Humana Pharmaceutical Policy Updates »

The following Medical Policies have been revised.

November 2017

Policy Name Reviewed Date
Actimmune® (interferon gamma-1b) 11/8/2017
Basaglar® (insulin glargine) 11/8/2017
Boniva® and generic ibandronate sodium Injection 11/8/2017
Botox® (Botulinum Toxin) 11/8/2017
Buprenorphine Containing Products 11/8/2017
Buprenorphine Containing Products 11/8/2017
Buprenorphine Containing Products 11/8/2017
Buprenorphine Containing Products 11/8/2017
Crofelemer Products 11/8/2017
DUOPA® (carbidopa and levodopa enteral suspension) 11/8/2017
Diclofenac Topical Gel 11/8/2017
Egrifta® (tesamorelin acetate) 11/8/2017
Endari™ (L-glutamine) 11/8/2017
Ezetimibe Containing Products 11/8/2017
Forteo® (teriparatide injection) 11/8/2017
Forteo® (teriparatide) 11/8/2017
Giazo® (balsalazide disodium) 11/8/2017
Glatiramer Products (Copaxone, glatiramer) 11/8/2017
Inhaled Corticosteroids 11/8/2017
Intranasal Rhinitis Agents 11/8/2017
Korlym® (mifepristone) 11/8/2017
Kymriah™ (tisagenlecleucel) 11/8/2017
Lotronex® (alosetron HCl) 11/8/2017
Lupaneta Pack® (leuprolide acetate and norethindrone acetate) 11/8/2017
Member Cost-Share Waiver: Contraceptives 11/8/2017
Mylotarg® (gemtuzumab ozogamicin) 11/8/2017
Non-Sedating Antihistamines 11/8/2017
Ophthalmic Non-Steroidal Anti-Inflammatory Drugs 11/8/2017
Ophthalmic Non-Steroidal Anti-Inflammatory Drugs 11/8/2017
Ozurdex® (dexamethasone intravitreal implant) 11/8/2017
Prolia® (denosumab) 11/8/2017
Qutenza® (capsaicin) 8% patch 11/8/2017
Reclast® (zoledronic acid) 11/8/2017
Rytary™ (carbidopa and levodopa extended-release capsule) 11/8/2017
Simponi® Aria™ (golimumab) 11/8/2017
Stelara® (ustekinumab) 11/8/2017
Sustol® (granisetron) 11/8/2017
Tasmar® (tolcapone) 11/8/2017
VPRIV® (velaglucerase alfa) 11/8/2017
Vivitrol® (naltrexone for extended release injectable suspension) 11/8/2017
Vivlodex® (meloxicam) 11/8/2017
XHANCE™ (fluticasone propionate) 11/8/2017
Xiidra (lifitegrast ophthalmic solution) 11/8/2017
Xopenex HFA® (levalbuterol) 11/8/2017
Zanaflex® (tizanidine) 11/8/2017
Zanaflex® (tizanidine) 11/8/2017
Zegerid® (omeprazole, sodium bicarbonate) 11/8/2017
Sprix® (ketorolac tromethamine) nasal spray 11/2/2017
Vyxeos™ (daunorubicin and cytarabine) liposome 11/2/2017

 

Click here to view the Humana Pharmaceutical Policy Updates »

 

Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!

Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

error: Content is protected !!